Table 3.

Skin and mucosal adverse events (all cycles) for arms A and B

Arm A AE aNumber of patients with an AE by dose (%)
7.5–240480575670All
(N = 14)(N = 6)(N = 12)(N = 5)(N = 37)
Skin4 (29)5 (83)10 (83)5 (100)24 (65%)
Grade 3/40001 (20)1 (5%)
Mucosal1 (7)3 (50)9 (75)4 (80)17 (46%)
Grade 3/4001 (8)2 (40)3 (8%)
Arm B AEa Number of patients with an AE by dose, %
670940All
(N = 14)(N = 6)(N = 20)
Skin9 (64)5 (83)14 (70%)
Grade 3/401 (17)1 (5%)
Mucosal3 (21)4 (67)7 (35%)
Grade 3/401 (17)1 (5%)
  • aIncludes all adverse events considered as skin or mucosal.